Thomas Cluzeau, MD, PhD, Central University Hospital of Nice, Nice, France, shares his opinion on the goal of treatment in acute myeloid leukemia (AML), highlighting factors to consider when treating patients, and the importance of discussing and communicating with patients to better understand what is best. This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.